Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6026
Source ID: NCT01599338
Associated Drug: Liraglutide
Title: Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus|Overweight
Interventions: DRUG: Liraglutide
Outcome Measures: Primary: Change in liking and wanting for protein, lipid and glucid foods, 3 months|Change in sensory specific satiety for protein, lipid and glucid foods, 3 months|Change in gustative detection thresholds for sweet, bitter and salty tastes, 3 months|Change in appetite, desire to eat, pleasure in eating, 3 months | Secondary: Change in body mass composition (Dual Energy XRay Absorptiometry), 3 months|Change in plasma ghrelin, leptin, and HbA1c levels, 3 months
Sponsor/Collaborators: Sponsor: Centre Hospitalier Universitaire Dijon
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Start Date: 2011-01
Completion Date: 2011-09
Results First Posted:
Last Update Posted: 2012-06-01
Locations: CHU Dijon, Dijon, Bourgogne, 21000, France
URL: https://clinicaltrials.gov/show/NCT01599338